About me:
After studying Biology at the RWTH Aachen University, I began my PhD in the lab of Juanma Vaquerizas at the Max Planck Institute for Molecular Biomedicine in Germany, investigating the RNA modification m6A and the methyltransferases METTL3 and METTL14. This was followed by a brief period at The Institute of Cancer Research, before starting my Postdoc position in the Genomic Variation and Disease group at the LMS.
The genomic variation and disease team at the LMS started in 2024. Led by Lila Allou, it aims to understand the molecular consequences of SVs affecting noncoding regions in development and disease, thereby improving rare disease diagnosis and identifying potential therapeutic targets in cancer.